AU5273200A - Emulsion vehicle for poorly soluble drugs - Google Patents

Emulsion vehicle for poorly soluble drugs

Info

Publication number
AU5273200A
AU5273200A AU52732/00A AU5273200A AU5273200A AU 5273200 A AU5273200 A AU 5273200A AU 52732/00 A AU52732/00 A AU 52732/00A AU 5273200 A AU5273200 A AU 5273200A AU 5273200 A AU5273200 A AU 5273200A
Authority
AU
Australia
Prior art keywords
poorly soluble
soluble drugs
emulsion vehicle
emulsion
vehicle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52732/00A
Inventor
Panayiotis P. Constantinides
Karel J Lambert
Steven C. Quay
Alexander K. Tustian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sonus Pharmaceuticals Inc
Original Assignee
Sonus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/317,499 external-priority patent/US6660286B1/en
Application filed by Sonus Pharmaceuticals Inc filed Critical Sonus Pharmaceuticals Inc
Publication of AU5273200A publication Critical patent/AU5273200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU52732/00A 1999-05-24 2000-05-17 Emulsion vehicle for poorly soluble drugs Abandoned AU5273200A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US31749599A 1999-05-24 1999-05-24
US09/317,499 US6660286B1 (en) 1997-01-07 1999-05-24 Emulsion vehicle for poorly soluble drugs
US09317499 1999-05-24
US09317495 1999-05-24
US15612899P 1999-09-27 1999-09-27
US60156128 1999-09-27
PCT/US2000/013572 WO2000071163A1 (en) 1999-05-24 2000-05-17 Emulsion vehicle for poorly soluble drugs

Publications (1)

Publication Number Publication Date
AU5273200A true AU5273200A (en) 2000-12-12

Family

ID=27387807

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52732/00A Abandoned AU5273200A (en) 1999-05-24 2000-05-17 Emulsion vehicle for poorly soluble drugs

Country Status (9)

Country Link
EP (1) EP1185301A1 (en)
JP (1) JP2003500368A (en)
KR (1) KR20070058028A (en)
AU (1) AU5273200A (en)
BR (1) BR0010794A (en)
CA (1) CA2373994A1 (en)
MX (1) MXPA01011981A (en)
TW (1) TWI290052B (en)
WO (1) WO2000071163A1 (en)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727280B2 (en) 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US20080070981A1 (en) 2000-02-23 2008-03-20 Henryk Borowy-Borowski Water-soluble compositions of bioactive lipophilic compounds
US6632443B2 (en) 2000-02-23 2003-10-14 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
JP2003513019A (en) 1999-09-27 2003-04-08 ソーナス ファーマシューティカルス，インコーポレイテッド Composition of tocol-soluble therapeutic agent
US6828346B2 (en) * 1999-10-25 2004-12-07 Supergen, Inc. Methods for administration of paclitaxel
US6136846A (en) 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
US8618085B2 (en) 2000-04-28 2013-12-31 Koasn Biosciences Incorporated Therapeutic formulations of desoxyepothilones
US6589968B2 (en) 2001-02-13 2003-07-08 Kosan Biosciences, Inc. Epothilone compounds and methods for making and using the same
WO2002026208A2 (en) * 2000-09-27 2002-04-04 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
EP1337273A2 (en) 2000-11-28 2003-08-27 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
US6893859B2 (en) 2001-02-13 2005-05-17 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
FR2820975B1 (en) * 2001-02-21 2004-03-12 Oreal COMPOSITION FOR TOPICAL APPLICATION COMPRISING AT LEAST ONE HYDROXYSTILBENE AND AT LEAST ONE POLYOL FOR SOLUBILIZING THE HYDROXYSTILBENE
US6858227B1 (en) 2001-11-21 2005-02-22 Sonus Pharmaceuticals, Inc. Vitamin E conjugates
AU2002357012A1 (en) * 2001-11-27 2003-06-10 Transform Pharmaceuticals, Inc. Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
WO2003049716A1 (en) * 2001-12-13 2003-06-19 Ranbaxy Laboratories Limited Stable topical formulation of clarithromycin
DE60236456D1 (en) * 2001-12-19 2010-07-01 Res Dev Foundation LIPOSOMAL DELIVERY OF COMPOUNDS ON VITAMIN E BASE
JP4502641B2 (en) * 2002-01-24 2010-07-14 ティルタン ファーマ リミテッド Anti-cancer combinations and methods of use
PT1509256E (en) 2002-05-24 2009-10-15 Angiotech Int Ag Compositions and methods for coating medical implants
FR2840614B1 (en) 2002-06-07 2004-08-27 Flamel Tech Sa POLYAMINOACIDS FUNCTIONALIZED BY ALPHA-TOCOPHEROL AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS
JP4641941B2 (en) 2002-11-07 2011-03-02 コーサン バイオサイエンシーズ， インコーポレイテッド Trans-9,10-dehydroepothilone C and D, their analogs, and methods of making them
WO2004073692A1 (en) * 2003-02-18 2004-09-02 Yamashita, Shinji Hard capsule of hardly water-soluble drug
US8802116B2 (en) 2003-02-27 2014-08-12 Novasel Australia Pty. Ltd. Poloxamer emulsion preparations
FR2855521B1 (en) 2003-05-28 2005-08-05 Flamel Tech Sa POLYAMINOACIDES FUNCTIONALIZED BY AT LEAST ONE YDROPHOBIC GROUP AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS.
US7691838B2 (en) 2003-05-30 2010-04-06 Kosan Biosciences Incorporated Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
EP1498120A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid formulations for the oral administration of taxoids
CA2536283A1 (en) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Pharmaceutical preparations having an improved solubility
EP1510206A1 (en) * 2003-08-29 2005-03-02 Novagali Pharma SA Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
AU2004285037B2 (en) * 2003-10-29 2010-07-22 Sonus Pharmaceuticals, Inc. Tocopherol-modified therapeutic drug compounds
US20050096365A1 (en) * 2003-11-03 2005-05-05 David Fikstad Pharmaceutical compositions with synchronized solubilizer release
ATE516011T1 (en) * 2003-12-19 2011-07-15 Schering Corp PHARMACEUTICAL COMPOSITIONS OF A2A RECEPTOR ANTAGONIST
US8003122B2 (en) 2004-03-31 2011-08-23 Cordis Corporation Device for local and/or regional delivery employing liquid formulations of therapeutic agents
US7989490B2 (en) * 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
US8541413B2 (en) 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
EP3173072A1 (en) 2004-10-01 2017-05-31 Ramscor, Inc. Conveniently implantable sustained release drug compositions
GT200500310A (en) * 2004-11-19 2006-06-19 ORGANIC COMPOUNDS
FR2879932B1 (en) * 2004-12-27 2007-03-23 Aventis Pharma Sa FORMULATIONS INJECTABLE OR ORALLY ADMINISTRATIVE OF AZETIDINE DERIVATIVES
DK1848431T3 (en) * 2005-02-09 2016-04-18 Santen Pharmaceutical Co Ltd LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
CA3054535A1 (en) 2005-02-18 2006-08-24 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
EP1862183B1 (en) * 2005-03-14 2010-11-03 Otsuka Pharmaceutical Factory, Inc. Kit comprising drug and fat emulsion
BRPI0610411A2 (en) 2005-04-29 2010-06-22 Kosan Biosciences Inc use of 17-allylamino-17-demethoxygeldanamycin (17-aag) or 17-aminogeldanamycin (17-ag) or a 17-aag or 17-ag prodrug as well as a pharmaceutical formulation
ITRM20050418A1 (en) * 2005-08-04 2007-02-05 Sigma Tau Ind Farmaceuti IMMEDIATE RELEASE THERAPEUTIC SYSTEMS FOR THE IMPROVED ORAL ABSORPTION OF 7 - [(E) -T-BUTYLOSSIMINOMETHYL] CAMPTOTECIN.
RS53591B1 (en) * 2005-09-28 2015-02-27 Auris Medical Ag Pharmaceutical compositions for the treatment of inner ear disorders
WO2007104173A2 (en) * 2006-03-10 2007-09-20 Laboswiss Ag Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof
KR100917809B1 (en) * 2006-05-22 2009-09-18 에스케이케미칼주식회사 Stable Pharmaceutical Composition containing Docetaxel
JP5301995B2 (en) 2006-08-29 2013-09-25 富士フイルム株式会社 Hydrophilic matrix encapsulating poorly water-soluble compounds and process
WO2008088037A1 (en) * 2007-01-18 2008-07-24 National University Corporation Chiba University Finely particulate medicinal preparation
KR101024742B1 (en) * 2007-12-31 2011-03-24 주식회사 삼양사 Amphiphilic Block Copolymer Micelle Composition Containing Taxane and Manufacturing Process of The Same
WO2009084801A1 (en) * 2007-12-31 2009-07-09 Samyang Corporation Amphiphilic block copolymer micelle composition containing taxane and manufacturing process of the same
US9801818B2 (en) 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
US8409601B2 (en) 2008-03-31 2013-04-02 Cordis Corporation Rapamycin coated expandable devices
US8420110B2 (en) 2008-03-31 2013-04-16 Cordis Corporation Drug coated expandable devices
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
EP3143996A1 (en) 2009-08-14 2017-03-22 OPKO Health, Inc. Intravenous formulations of neurokinin 1-antagonists
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
EP2480209A1 (en) 2009-09-23 2012-08-01 Indu Javeri Methods for the preparation of liposomes comprising docetaxel
JP5486690B2 (en) * 2009-11-16 2014-05-07 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ Pharmaceutical composition of melanocortin receptor ligand
US20110144578A1 (en) * 2009-12-11 2011-06-16 Stephen Pacetti Hydrophobic therapueutic agent and solid emulsifier coating for drug coated balloon
CN102101863B (en) 2009-12-17 2014-10-15 唐莉 Novel epoxy thiazone compounds and preparation method and application thereof
TWI438009B (en) * 2010-02-19 2014-05-21 Teikoku Pharma Usa Inc Taxane pro-emulsion formulations and methods making and using the same
JP5876467B2 (en) * 2010-03-17 2016-03-02 クローダ，インコーポレイティド Polymer surfactant
HUE030207T2 (en) 2010-03-29 2017-04-28 Abraxis Bioscience Llc Methods of treating cancer
MX2012011155A (en) 2010-03-29 2012-12-05 Abraxis Bioscience Llc Methods of enhancing drug delivery and effectiveness of therapeutic agents.
AU2011261685B2 (en) 2010-06-04 2016-02-11 Abraxis Bioscience, Llc Methods of treatment of pancreatic cancer
AU2011287873B2 (en) * 2010-08-04 2014-09-25 Grünenthal GmbH Pharmaceutical dosage form comprising 6'-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
AU2012250050B2 (en) * 2011-04-28 2017-04-06 Platform Brightworks Two, Ltd. Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
JO3685B1 (en) * 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc Non-aqueous taxane nanodispersion formulations and methods of using the same
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CN105267145B (en) * 2015-11-01 2019-06-21 袁旭东 The self-emulsifying formulation of diphosphonate and related dosage form
GB201522764D0 (en) 2015-12-23 2016-02-03 Nucana Biomed Ltd Formulations of phosphate derivatives
US20200093751A1 (en) * 2016-06-28 2020-03-26 Der-Yang Tien Chemoprotective/chemoactive nanodroplets and methods of use thereof
JP2018024592A (en) * 2016-08-09 2018-02-15 株式会社ブレインヘルス Composition comprising antibiotic
JP2020503269A (en) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド Oral testosterone undecanoate therapy
EP3424493A1 (en) * 2017-07-07 2019-01-09 SolMic Research GmbH Stable cannabinoid compositions
EP3424494A1 (en) * 2017-07-07 2019-01-09 SolMic Research GmbH Stable cannabinoid compositions
KR102197257B1 (en) * 2017-10-19 2020-12-31 단국대학교 천안캠퍼스 산학협력단 Stabilizing composition for aqueous suspension of entecavir fatty acid esters analogs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
KR100239799B1 (en) * 1995-01-21 2000-02-01 손경식 Cyclosporin a solid micelle dispersion for oral administration, the preparation method thereof and its solid dosage form
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
NZ314060A (en) * 1997-01-13 1997-08-22 Bernard Charles Sherman Pharmaceutical microemulsion preconcentrate comprising cyclosporin dissolved in a solvent system comprising hydrophobic solvent(s) and surfactant(s)
AU729724B2 (en) * 1997-04-18 2001-02-08 Taisho Pharmaceutical Co., Ltd. Microemulsion
GB9715759D0 (en) * 1997-07-26 1997-10-01 Danbiosyst Uk New emulsion formulations

Also Published As

Publication number Publication date
MXPA01011981A (en) 2003-09-04
BR0010794A (en) 2002-06-04
WO2000071163A1 (en) 2000-11-30
CA2373994A1 (en) 2000-11-30
EP1185301A1 (en) 2002-03-13
KR20070058028A (en) 2007-06-07
JP2003500368A (en) 2003-01-07
TWI290052B (en) 2007-11-21

Similar Documents

Publication Publication Date Title
AU5273200A (en) Emulsion vehicle for poorly soluble drugs
IL130737A0 (en) Emulsion vehicle for poorly soluble drugs
AU2331801A (en) Improved pharmaceutical compositions for poorly soluble drugs
AU1071301A (en) Pharmaceutical compounds
EP1104721A3 (en) Passenger restraint system
AU1632601A (en) System and method for pharmacy administration
AU7595900A (en) Weigh-in-motion scale for vehicles
AU2514200A (en) Traction-enhancing system for vehicles
AU7912100A (en) Pharmaceutical composition comprising an antigen
AU7696800A (en) System for guiding vehicles
AU1090001A (en) Vehicle back
AU2904900A (en) Support system for functional unit
AU5686400A (en) Method for producing quickly decomposable solid pharmaceutical preparations
AU7437800A (en) Vehicle
AU7815000A (en) Targeted drug activation
AU5050400A (en) A platform for a vehicle
AU2001293177A1 (en) Emulsion vehicle for poorly soluble drugs
AU5722900A (en) Pharmaceutical compounds
AU5695000A (en) Imaging system for vehicles when overtaking
AU2001291691A1 (en) Drugs for incontinence
AU5853600A (en) Seat for vehicle
AU3433600A (en) Pedal-actuated vehicle built for three
AU6843400A (en) Jack for vehicles
AU2983100A (en) Drug delivery vehicle
ZA9898B (en) Emulsion vehicle for poorly soluble drugs

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase